Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19
Journal of Pharmaceutical Sciences · 2024
DOI: 10.1016/j.xphs.2023.07.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Matthew N O'Brien Laramy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., Worldwide Research, Development, & Medical, Lake Forest, IL 60045, USA. Hauptthemen laut MEDLINE: Prodrugs, COVID-19 Drug Treatment, Solubility, Esters. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
PF-07304814 is a water-soluble phosphate ester prodrug of a small molecule inhibitor for the SARS CoV-2 3CL protease designed for the treatment of COVID-19. The amphiphilicity and self-assembly behavior of the prodrug was investigated computationally and experimentally via multiple orthogonal techniques to better design formulations for intravenous infusion. The self-assembly of PF-07304814 into micellar structures enabled an increase in the solubility of lipophilic impurities by up to 1900x in clinically relevant formulations. The observed solubilization could help extend the drug product shelf-life and in use stability through inhibition of precipitation, without the need for solubilizing excipients. The work presented in this manuscript provides a roadmap for the characterization of prodrug self-assembly and highlights the potential for prodrug modifications to enhance solubility of both active ingredients and impurities and to extend drug product shelf-life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pfizer Inc., Worldwide Research, Development, & Medical, Lake Forest, IL 60045, USA.
- Pfizer Inc., Worldwide Research, Development, & Medical, Groton 06340, CT.
- Pfizer Inc., Worldwide Research, Development, & Medical, Sandwich, UK.
- Pfizer Inc., Worldwide Research, Development, & Medical, Cambridge, MA 02139, USA.
- Pfizer Inc., Worldwide Research, Development, & Medical, Sandwich, UK. Electronic address: martyn.ticehurst@pfizer.com.
Zitieren
APA
O'Brien Laramy, M. N., Bezawada, P., Horst, R., Jaini, R., Lillis, J., Liu, Y., Luthra, S., Nguyen, B., Patel, N., Soni, S., Sullivan, B. P., Thiel, A., & Ticehurst, M. D. (2024). Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2023.07.024
Vancouver
O'Brien Laramy MN, Bezawada P, Horst R, Jaini R, Lillis J, Liu Y, et al. Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2023.07.024
BibTeX
@article{OBrienLaramy2024,
author = {O'Brien Laramy, Matthew N and Bezawada, Padmavani and Horst, Reto and Jaini, Rohit and Lillis, Jonathan and Liu, Yizhou and Luthra, Suman and Nguyen, Bao and Patel, Nandini and Soni, Smita and Sullivan, Bradley P and Thiel, Andrew and Ticehurst, Martyn D},
title = {Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19},
journal = {Journal of Pharmaceutical Sciences},
year = {2024},
doi = {10.1016/j.xphs.2023.07.024}
}
EUVIMED